Published in:
Volume 4 / Year 2015 / Issue 3

Regulatory requirements for the development and registration of biosimilars in South Africa

Author(s): , ,
Page: 150-2

Abstract: In South Africa, medicines are registered and regulated in terms of the Medicines and Related Substances Control Act (Act 101 of 1965), as amended, and the regulations to this… Read More »

Go Back Print